Topic

Aetna (CVS Health)

A collection of 1351 issues

How to Get Abecma (idecabtagene vicleucel) Covered by Aetna (CVS Health) in Ohio: Appeals Guide and State Protections

Answer Box: Your Path to Abecma Coverage in Ohio Aetna (CVS Health) requires prior authorization for Abecma (idecabtagene vicleucel) in Ohio, covering adults ≥18 with relapsed/refractory multiple myeloma after ≥2 prior lines including an IMiD, proteasome inhibitor, and anti-CD38 antibody. Submit complete documentation to CVS Caremark Specialty (1-866-814-5506) with
6 min read

How to Get Gilenya (Fingolimod) Covered by Aetna CVS Health in North Carolina: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Gilenya (Fingolimod) Covered by Aetna CVS Health in North Carolina Aetna requires prior authorization for Gilenya (fingolimod) with approval valid for 12 months. Your neurologist must submit documentation including MS diagnosis (ICD-10 G35), baseline EKG, ophthalmology exam, vaccination records, and prior therapy history. Submit requests at least
6 min read

How to Get Cometriq (Cabozantinib) Covered by Aetna CVS Health in Illinois: Prior Authorization Guide and Appeals Process

Answer Box: Getting Cometriq Covered by Aetna CVS Health in Illinois Cometriq (cabozantinib) requires prior authorization from Aetna CVS Health for medullary thyroid carcinoma (MTC) coverage. Submit your PA request via the Availity provider portal or fax to 1-888-267-3277 with oncologist attestation, confirmed MTC diagnosis, and documentation of disease progression.
5 min read

How to Get Mavenclad (Cladribine Tablets) Covered by Aetna CVS Health in Georgia: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Mavenclad Covered by Aetna CVS Health in Georgia Aetna CVS Health requires prior authorization for Mavenclad (cladribine tablets) with documented failure of at least 2 disease-modifying therapies, lymphocyte count ≥800 cells/μL, and neurologist prescription. Submit PA via Availity portal or fax to 1-866-249-6155. If denied, you
5 min read

Aetna (CVS Health)'s Coverage Criteria for Ultomiris (ravulizumab) in Virginia: What Counts as "Medically Necessary"?

Quick Answer: Aetna (CVS Health) requires prior authorization for Ultomiris (ravulizumab) across all FDA-approved indications in Virginia. Submit form GR-69447 with diagnosis-specific labs, REMS compliance proof, and vaccination records. If denied, Virginia's State Corporation Commission provides free external review within 120 days. First step: Verify your coverage and
6 min read

How to Get Translarna (Ataluren) Covered by Aetna CVS Health in Pennsylvania: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Translarna (Ataluren) Covered by Aetna CVS Health in Pennsylvania Current Status: Translarna (ataluren) lacks FDA approval as of late 2024, so Aetna CVS Health typically denies coverage for nonsense mutation Duchenne muscular dystrophy (DMD) in Pennsylvania. However, you can still pursue coverage through prior authorization with medical
6 min read